Similar articles

• FDA, Roche to implement new dispensing procedures for isotretinoin.

  Young D. Young D. Am J Health Syst Pharm. 2001 Dec 15;58(24):2359-60. doi: 10.1093/ajhp/58.24.2359. Am J Health Syst Pharm. 2001. PMID: 11794946 No abstract available.
• Ethical and legal aspects of teratogenic medications: the case of isotretinoin.

  Moskop JC, Smith ML, De Ville K. Moskop JC, et al. J Clin Ethics. 1997 Fall;8(3):264-78. J Clin Ethics. 1997. PMID: 9436085 Review. No abstract available.
• How to ensure fetal safety when mothers use isotretinoin (Accutane).

  Koren G, Pastuszak A. Koren G, et al. Can Fam Physician. 1997 Feb;43:216-9. Can Fam Physician. 1997. PMID: 9040906 Free PMC article. Review. No abstract available.
• [Probable acute hemorrhagic colitis caused by isotretinoin with a test of repeated administration].

  Deplaix P, Barthélémy C, Védrines P, Perrot JL, Lanthier K, Pignato F, Audigier JC. Deplaix P, et al. Gastroenterol Clin Biol. 1996 Feb;20(1):113-4. Gastroenterol Clin Biol. 1996. PMID: 8734319 French. No abstract available.
• [Isotretinoin associated with risk of suicide].

  Ramió Montero E, Iglesias Sancho MI, Eguileor Partearroyo B. Ramió Montero E, et al. Farm Hosp. 2012 Sep-Oct;36(5):443-4. doi: 10.1016/j.farma.2011.08.008. Epub 2012 Jan 21. Farm Hosp. 2012. PMID: 22266200 Spanish. No abstract available.